Abstract:Background Diagnosing MS through magnetic resonance imaging (MRI) requires extensive clinical experience and tedious work. Furthermore, MRI-indicated MS lesion locations rarely align with the patients’ symptoms and often contradict with pathology studies. Our lab has developed and modified a novel diffusion basis spectrum imaging (DBSI) technique to address the shortcomings of MRI-based MS diagnoses. Although primary DBSI metrics have been demonstrated to be associated with axonal injury/loss, demyelination and inflammation, a more detailed analysis using multiple DBSI-structural metrics to improve the accuracy of MS lesion detection and differentiation is still needed. Here we report that Diffusion Histology Imaging (DHI), an improved approach that combines a deep neural network (DNN) algorithm with improved DBSI analyses, accurately detected and classified various MS lesion types. Methods Thirty-eight multiple sclerosis patients were scanned with T2-weighted imaging (T2WI) using fluid attenuated inversion recovery (FLAIR), T1-weighted imaging (T1WI) using magnetization-prepared rapid acquisition with gradient echo (MPRAGE), magnetization transfer contrast (MTR) imaging and diffusion-weighted imaging. The imaging results identified 43,261 voxels from 91 persistent black hole (PBH) lesions, 89 persistent gray hole (PGH) lesions, 16 acute gray hole (AGH) lesions, 189 non-black hole (NBH) lesions and 113 normal-appearing white matter (NAWM) areas. Data extracted from these lesions were randomly split into training, validation, and testing groups with an 8:1:1 ratio. The DNN was constructed with 10 fully-connected hidden layers using TensorFlow 2.0 in Python. Batch normalization and dropout regularization were used for model optimization. Results Each MS lesion type had unique DBSI derived diffusion metric profiles. Based on these DBSI diffusion metric profiles, DHI achieved a 93.6% overall concordance with neurologist determinations of all five MS lesions, compared with 74.3% from conventional MRI (cMRI)-DNN model, 78.2% from MTR-DNN model, and 80% from DTI-DNN model. DHI also achieved greater performances on detecting individual MS lesion types compared to other models. Specifically, DHI showed great performances on prediction of PBH (AUC: 0.991; F1-score: 0.923), PGH (AUC: 0.977; F1-score: 0.823) and AGH (AUC: 0.987; F1-score: 0.887), which significantly outperformed other models. Conclusions DHI significantly improves the detection and classification accuracy for various MS lesion types, which could greatly aid the clinical decisions of neurologists and neuroradiologists. The efficacy and efficiency of this DNN model shows great promise for clinical application. ### Competing Interest Statement Dr. Anne H. Cross has performed consulting for: Biogen, Celgene, EMD Serono, Genentech/Roche, and Novartis, all of which have no direct relation to the current study. Other authors declare no competing interests, financial or otherwise. ### Clinical Trial This study is not a randomized controlled trial and the experimental protocol has been published before. Thus, the study was not registered as a clinical trial. ### Funding Statement This study was supported by the National Institutes of Health (NIH) P01 NS059560. ### Author Declarations All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript. Yes I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable. Yes The datasets and codes from this study are available from the corresponding author on reasonable request.

Deep Learning with Diffusion Basis Spectrum Imaging for Classification of Multiple Sclerosis Lesions

M-DDC: MRI Based Demyelinative Diseases Classification with U-Net Segmentation and Convolutional Network

Diffusion Histology Imaging to Improve Lesion Detection and Classification in Multiple Sclerosis

Joint Radiomics and Spatial Distribution Model for MRI-based Discrimination of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin-Oligodendrocyte-glycoprotein-igg-associated Disorder.

Multiple Sclerosis Lesion Analysis in Brain Magnetic Resonance Images: Techniques and Clinical Applications

Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: emerging machine learning techniques and future avenues

Improving the classification of multiple sclerosis and cerebral small vessel disease with interpretable transfer attention neural network

Interpretable deep learning as a means for decrypting disease signature in multiple sclerosis

Advanced Analysis of Diffusion Tensor Imaging Along With Machine Learning Provides New Sensitive Measures of Tissue Pathology and Intra-Lesion Activity in Multiple Sclerosis

Image Segmentation with Priority Based Apposite Feature Extraction Model for Detection of Multiple Sclerosis in MR Images Using Deep Learning Technique

Deep Learning on Conventional Magnetic Resonance Imaging Improves the Diagnosis of Multiple Sclerosis Mimics

Investigation of an efficient multi-modal convolutional neural network for multiple sclerosis lesion detection

Efficient Segmentation Model Using MRI Images and Deep Learning Techniques for Multiple Sclerosis Classification

Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging

Deep Attention and Graphical Neural Network for Multiple Sclerosis Lesion Segmentation From MR Imaging Sequences

Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model

Automated Segmentation of Multiple Sclerosis Lesions using Deep Learning

Deep Learning With Data Enhancement for the Differentiation of Solitary and Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion

Automated Classification of Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions Using Deep Learning

BOLD signal within and around white matter lesions distinguishes multiple sclerosis and non-specific white matter disease: a three-dimensional approach

Multiple Sclerosis Lesion Segmentation from Brain MRI via Fully Convolutional Neural Networks